SCHEMBL20734006

SCHEMBL20734006

COc1cc(OC)cc(-c2cc3cnc(S(C)(=O)=O)nc3[nH]c2=O)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 10/20 0.40
FGFR2 P21802 2/20 0.40
FGFR4 P22455 2/20 0.40
FGFR3 P22607 2/20 0.40
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
LMNA P02545 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
TLR9 Q9NR96 1/20 0.36
PIK3CD O00329 1/20 0.35
PIK3CA P42336 1/20 0.35
PIK3CB P42338 1/20 0.35
PIK3CG P48736 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
EGFR P00533 1/20 0.35
SRC P12931 1/20 0.34
CCNB2 O95067 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29545714 1.00 FGFR1 (0.40) FGFR1FGFR2FGFR4FGFR3NPC1
SCHEMBL22719106 0.89 RIPK2 (0.43) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL29535863 0.89 RIPK2 (0.43) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL29545761 0.82 FGFR1 (0.37) FGFR1FGFR2FGFR4NPC1RAB9A
SCHEMBL20733929 0.82 FGFR1 (0.37) FGFR1FGFR2FGFR4NPC1RAB9A
SCHEMBL20733926 0.80 SIK2 (0.48) FGFR1FGFR2FGFR4FGFR3NPC1
SCHEMBL29545734 0.80 SIK2 (0.48) FGFR1FGFR2FGFR4FGFR3NPC1
SCHEMBL16071669 0.79 FGFR1 (0.41) FGFR1FGFR2FGFR4FGFR3NPC1
SCHEMBL16072024 0.78 FGFR4 (0.42) FGFR1FGFR2FGFR4FGFR3NPC1
SCHEMBL20734021 0.77 FGFR1 (0.40) FGFR1FGFR2FGFR4FGFR3NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019029541-A1 FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITOR AND USE THEREOF 南京药捷安康生物科技有限公司 2019-02-14 WO disclosed